Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

NICE Alzheimer’s decision unchanged

Following consultation with stakeholders, NICE has announced that its 2006 guidance on the use of drugs to treat Alzheimer's remains unchanged

NHS financial shortfall

The health service faces a shortfall of £8-£10bn from 2011 the NHS Confederation warns

Female doctors to become majority in UK

Research from the Royal College of Physicians shows that by 2017, the majority of doctors in the UK will be women

O2 brings NFC solution to health sector

O2 is showcasing its new Near Field Communications (NFC) technology and demonstrating how it can benefit UK residents of sustainable homes, particularly those in assisted living who require home care

Cheaper generic drugs save NHS £400m

In 2008, almost £400m was saved by the DH, the NHS and PCTs in England, through more cost-effective prescribing

New resource launched – NHS Evidence

A new service has been launched that provides health and social care practitioners with access to clinical and non-clinical evidence

NICE vice-chair to head NHS trust

Mark Taylor, vice-chair of NICE has stepped down and taken up a new role as chair of an NHS Mental Health Trust

Improved systems in Scotland

The NHS in Scotland has made significant improvements to services but still requires better information to reduce its drugs bill

New blueprint for people with autism

DH announced that a new blueprint for commissioning high-quality care for people with autism should improve the services available to them

New guideline centre in UK

Four National Collaborating Centres that develop clinical guidelines for the NHS have merged creating the largest clinical guideline centre in the UK

NHS health checks

Health Secretary Alan Johnson has announced that everyone aged between 40 and 74 years old in England will be invited for a free health check

GSK appeals against NICE’s Tyverb decision

GlaxoSmithKline has confirmed that it will appeal against NICE's decision earlier this month to deny NHS funding for Tyverb, a treatment for an aggressive form of advanced breast cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links